Dare Bioscience (DARE) Misses Q1 EPS by 50c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts DARE Hot Sheet
Join SI Premium – FREE
Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.50). Revenue for the quarter came in at $25.42 million.
For earnings history and earnings-related data on Dare Bioscience (DARE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OPay (OPAY) indicated to open at $17-$19, IPO priced at $16
- Reddit (RDDT) PT Lowered to $145 at Piper Sandler
- Digital Realty Trust (DLR) PT Raised to $229 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
